Has Ish Gupta received payments from drug or device companies?

Yes. Drug and device makers reported $2,609 in general payments to Ish Gupta across 92 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ish Gupta did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ish Gupta come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ish Gupta

Internal Medicine · Worcester, MANPI 1598747834

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $972 and has fallen 88.2% since, to $115 in 2025. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,609in general payments, 2019–2025

Across 92 payments — averaging $28.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$617
AstraZeneca$308
Pfizer$247
Grifols USA, LLC$149
Amgen$127
Boston Scientific$114
plus $1K from 14 others

What the payments were for

Food & beverage$2,609100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	22	$617
AstraZeneca(2 entities)	12	$308
Pfizer	13	$247
Grifols USA, LLC	2	$149
Amgen	1	$127
Boston Scientific	1	$114
Novartis	5	$114
Novo Nordisk	5	$107
Boehringer Ingelheim	4	$107
AbbVie	4	$106
Alnylam Pharmaceuticals Inc.	1	$87
Abiomed	4	$86
Neurelis, Inc.	2	$72
Actelion Pharmaceuticals US, Inc.	2	$65
Baxter Healthcare	3	$62
Janssen Scientific Affairs, LLC	3	$57
Inari Medical, Inc.	2	$55
Gilead	2	$47
Biomerieux Inc	2	$42
Lexicon Pharmaceuticals, Inc.	2	$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,609 in reported general payments places this provider in the 90th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts →

Other internal medicine in Worcester

David SchenkeinBoston$5M
Alan GarberCambridge$4.9M
John FallonBoston$1.8M
Michael MendelsohnBoston$1.6M
Sandra RichmanBrookline$1.4M
Gaurav SingalBoston$798K
Asit ParikhBoston$486K
Noopur RajeBoston$481K
Daniel KuritzkesBoston$443K
Xiuning leBoston$364K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →